HomePBIGF • OTCMKTS
add
Paradigm Biopharmaceuticals Ltd
Nakaraang pagsara
$0.14
Sakop ng taon
$0.11 - $0.27
Market cap
158.54M AUD
Average na Volume
1.02K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 7.48M | -45.24% |
Net na kita | -4.85M | 51.63% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -7.45M | 45.35% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 17.87M | -68.31% |
Kabuuang asset | 27.39M | -59.16% |
Kabuuang sagutin | 3.58M | -73.23% |
Kabuuang equity | 23.81M | — |
Natitirang share | 350.36M | — |
Presyo para makapag-book | 2.01 | — |
Return on assets | -68.30% | — |
Return on capital | -77.80% | — |
Cash Flow
Net change in cash
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -4.85M | 51.63% |
Cash mula sa mga operasyon | -7.46M | 45.60% |
Cash mula sa pag-invest | -23.10K | 0.00% |
Cash mula sa financing | -62.77K | -153.17% |
Net change in cash | -7.87M | 42.99% |
Malayang cash flow | -4.46M | 47.53% |
Tungkol
Itinatag
2014
Website
